miR-211 alleviates ischaemia/reperfusion-induced kidney injury by targeting TGFβR2/TGF-β/SMAD3 pathway

References

• Ortiz A, Justo P, Sanz A, et al. Targeting apoptosis in acute tubular injury. Biochem Pharmacol. 2003;66(8):1589–1594.
   PubMed Web of Science ®Google Scholar
• Pefanis A, Ierino FL, Murphy JM, et al. Regulated necrosis in kidney ischemia-reperfusion injury. Kidney Int. 2019;96(2):291–301.
   PubMed Web of Science ®Google Scholar
• Han SJ, Lee HT. Mechanisms and therapeutic targets of ischemic acute kidney injury. Kidney Res Clin Pract. 2019;38:427–440.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297.
   PubMed Web of Science ®Google Scholar
• Shekhar R, Priyanka P, Kumar P, et al. The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression. J Biol Chem. 2019;294(12):4381–4400.
   PubMed Web of Science ®Google Scholar
• Hu T, Chong Y, Lu S, et al. miR-339 promotes development of stem cell leukemia/lymphoma syndrome via downregulation of the BCL2L11 and BAX proapoptotic genes. Cancer Res. 2018;78:3522–3531.
   PubMed Web of Science ®Google Scholar
• Yong YX, Yang H, Lian J, et al. Up-regulated microRNA-199b-3p represses the apoptosis of cerebral microvascular endothelial cells in ischemic stroke through down-regulation of MAPK/ERK/EGR1 axis. Cell Cycle. 2019;18(16):1868–1881.
   PubMed Web of Science ®Google Scholar
• Fletcher CE, Sulpice E, Combe S, et al. Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer. Oncogene. 2019;38(28):5700–5724.
   PubMed Web of Science ®Google Scholar
• Wang K, Liu F, Liu CY, et al. The long noncoding RNA NRF regulates programmed necrosis and myocardial injury during ischemia and reperfusion by targeting miR-873. Cell Death Differ. 2016;23:1394–1405.
   PubMed Web of Science ®Google Scholar
• Qin D, Wang X, Li Y, et al. MicroRNA-223-5p and −3p cooperatively suppress necroptosis in ischemic/reperfused hearts. J Biol Chem. 2016;291:20247–20259.
   PubMed Web of Science ®Google Scholar
• Li Z, Li J, Tang N. Long noncoding RNA Malat1 is a potent autophagy inducer protecting brain microvascular endothelial cells against oxygen-glucose deprivation/reoxygenation-induced injury by sponging miR-26b and upregulating ULK2 expression. Neuroscience. 2017;354:1–10.
   PubMed Web of Science ®Google Scholar
• He X, Zheng Y, Liu S, et al. MiR-146a protects small intestine againstischemia/reperfusion injury by down-regulating TLR4/TRAF6/NF-κB pathway. J Cell Physiol. 2018;233:2476–2488.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Zhang S, Li Q, et al. miR-219a-5p ameliorates hepatic ischemia/reperfusion injury via impairing TP53BP2. Dig Dis Sci. 2019;64(8):2177–2186.
   PubMed Web of Science ®Google Scholar
• Liu Z, Yang Q, Wei Q, et al. The protective effect of miR-377 inhibitor against renal ischemia-reperfusion injury through inhibition of inflammation and oxidative stress via a VEGF-dependent mechanism in mice. Mol Immunol. 2019;106:153–158.
   PubMed Web of Science ®Google Scholar
• Hao J, Wei Q, Mei S, et al. Induction of microRNA-17-5p by p53 protects against renal ischemia-reperfusion injury by targeting death receptor 6. Kidney Int. 2017;91(1):106–118.
   PubMed Web of Science ®Google Scholar
• Zhang W, Shu L. Upregulation of miR-21 by ghrelin ameliorates ischemia/reperfusion-induced acute kidney injury by inhibiting inflammation and cell apoptosis. DNA Cell Biol. 2016;35:417–425.
   PubMed Web of Science ®Google Scholar
• Mir MC, Pavan N, Parekh DJ. Current paradigm for ischemia in kidney surgery. J Urol. 2016;195(6):1655–1663.
   PubMed Web of Science ®Google Scholar
• Xu X, Kriegel AJ, Jiao X, et al. miR-21 in ischemia/reperfusion injury: a double-edged sword? Physiol Genomics. 2014;46(21):789–797.
   PubMed Web of Science ®Google Scholar
• Li X, Pan X, Fu X, et al. MicroRNA-26a: an emerging regulator of renal biology and disease. Kidney Blood Press Res. 2019;44(3):287–297.
   PubMed Web of Science ®Google Scholar
• Chitnis NS, Pytel D, Bobrovnikova-Marjon E, et al. miR-211 is a prosurvival microRNA that regulates chop expression in a PERK-dependent manner. Mol Cell. 2012;48(3):353–364.
   PubMed Web of Science ®Google Scholar
• Ji L, Li X. Long noncoding RNA MEG3 is a tumor suppressor in choriocarcinoma by upregulation of microRNA-211. J Cell Physiol. 2019;234(12):22911–22920.
   PubMed Web of Science ®Google Scholar
• Zhang S, Ma H, Zhang D, et al. LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin/Fak/Src signaling. Cell Death Dis. 2018;9(7):742.
   PubMedGoogle Scholar
• Li XY, Zhang K, Jiang ZY, et al. MiR-204/miR-211 downregulation contributes to candidemia-induced kidney injuries via derepression of Hmx1 expression. Life Sci. 2014;102:139–144.
   PubMed Web of Science ®Google Scholar
• Takata T, Nonaka W, Iwama H, et al. Light exercise without lactate elevation induces ischemic tolerance through the modulation of microRNA in the gerbil hippocampus. Brain Res. 2020;1732:146710.
   PubMed Web of Science ®Google Scholar
• Liu W, Miao Y, Zhang L, et al. MiR-211 protects cerebral ischemia/reperfusion injury by inhibiting cell apoptosis. Bioengineered. 2020;11(1):189–200.
   PubMed Web of Science ®Google Scholar
• Moustakas A. The regulation of TGF beta signal transduction. Development. 2009;136:3699–3714.
   PubMed Web of Science ®Google Scholar
• Yu Y, Kanwar SS, Patel BB, et al. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells. Carcinogenesis. 2012;33:68–76.
   PubMed Web of Science ®Google Scholar
• Mishra S, Deng JJ, Gowda PS, et al. Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer. Oncogene. 2014;33:4097–4106.
   PubMed Web of Science ®Google Scholar
• Wang H, Liu J, Zong Y, et al. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer’s disease targets TGF-β type II receptor. Brain Res. 2010;1357:166–174.
   PubMed Web of Science ®Google Scholar
• Chu TH, Yang CC, Liu CJ, et al. miR-211 promotes the progression of head and neck carcinomas by targeting TGFβRII. Cancer Lett. 2013;337:115–124.
   PubMed Web of Science ®Google Scholar
• Jiang X, Xiang G, Wang Y, et al. MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-β RII. Mol Cells. 2012;33(6):545–551.
   PubMed Web of Science ®Google Scholar
• Janakiraman H, House RP, Gangaraju VK, et al. The long (lncRNA) and short (miRNA) of it: TGFβ-mediated control of RNA-binding proteins and noncoding RNAs. Mol Cancer Res. 2018;16(4):567–579.
   PubMed Web of Science ®Google Scholar
• Loboda A, Sobczak M, Jozkowicz A. TGF-beta1/Smads and miR-21 in renal fibrosis and inflammation. Mediators Inflamm. 2016;2016:1–12.
   Web of Science ®Google Scholar
• Wang B, Ma W, Yang H. Puerarin attenuates hypoxia-resulted damages in neural stem cells by up-regulating microRNA-214. Artif Cells Nanomed Biotechnol. 2019;47(1):2746–2753.
   PubMed Web of Science ®Google Scholar
• Niu CC, Lin SS, Yuan LJ, et al. Upregulation of miR-107 expression following hyperbaric oxygen treatment suppresses HMGB1/RAGE signaling in degenerated human nucleus pulposus cells. Arthritis Res Ther. 2019;21(1):42.
   PubMedGoogle Scholar
• Li Q, Yu P, Zeng Q, et al. Neuroprotective effect of hydrogen-rich saline in global cerebral ischemia/reperfusion rats: up-regulated tregs and down-regulated miR-21, miR-210 and NF-κB expression. Neurochem Res. 2016;41(10):2655–2665.
   PubMed Web of Science ®Google Scholar
• Zhang W, Shu L. Upregulation of miR-21 by ghrelin ameliorates ischemia/reperfusion-induced acute kidney injury by inhibiting inflammation and cell apoptosis. DNA Cell Biol. 2016;35(8):417–425.
   PubMed Web of Science ®Google Scholar
• Yue J, Si Y, Zhu T, et al. MicroRNA-187 reduces acute ischemic renal podocyte injury via targeting acetylcholinesterase. J Surg Res. 2019;244:302–311.
   PubMed Web of Science ®Google Scholar
• Li H, Ma Y, Chen B, et al. miR-182 enhances acute kidney injury by promoting apoptosis involving the targeting and regulation of TCF7L2/Wnt/β-catenins pathway. Eur J Pharmacol. 2018;831:20–27.
   PubMed Web of Science ®Google Scholar
• Dehaini H, Awada H, El-Yazbi A, et al. MicroRNAs as potential pharmaco-targets in ischemia-reperfusion injury compounded by diabetes. Cells. 2019;8(2):pii: E152.
   PubMed Web of Science ®Google Scholar
• Li EY, Zhao PJ, Jian J, et al. LncRNA MIAT overexpression reduced neuron apoptosis in a neonatal rat model of hypoxic-ischemic injury through miR-211/GDNF. Cell Cycle. 2019;18(2):156–166.
   PubMed Web of Science ®Google Scholar
• Peng Z, Li M, Tan X, et al. miR-211-5p alleviates focal cerebral ischemia-reperfusion injury in rats by down-regulating the expression of COX2. Biochem Pharmacol. 2020;177:113983.
   PubMed Web of Science ®Google Scholar
• Morikawa M, Derynck R, Miyazono K. TGF-β and the TGF-β family: context-dependent roles in cell and tissue physiology. Cold Spring Harb Perspect Biol. 2016;8(5):pii: a021873.
   PubMed Web of Science ®Google Scholar
• Goumans MJ, Valdimarsdottir G, Itoh S, et al. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. Embo J. 2002;21:1743–1753.
   PubMed Web of Science ®Google Scholar